Symrise secures China patent for SymSave® H (CN116509735B)
- China’s CNIPA granted patent CN116509735B for SymSave® H.
- The patent covers Hydroxyacetophenone–lipophilic compositions in aqueous formulations.
- Hydroxyacetophenone was introduced to cosmetics by Symrise in 2013 and serves antioxidant and soothing roles.
- The China grant is part of an international patent family also granted in the US, Korea, Japan, Brazil and India.
Patent grant and scope
China’s National Intellectual Property Administration (CNIPA) has granted patent CN116509735B for SymSave® H, providing exclusive protection for compositions that combine Hydroxyacetophenone with lipophilic components in aqueous systems and covering a broad range of formulation applications.
Ingredient function and history
Symrise introduced Hydroxyacetophenone to the cosmetics industry in 2013. The ingredient delivers robust antioxidant performance to stabilise products and protect formulation quality, offers soothing properties for skin exposed to everyday environmental stressors, and contributes to broad-spectrum product protection.
Customer and market impact
The China patent clarifies the technology’s originality and reinforces the value of sourcing the ingredient from its developer, supporting trust in authenticity, consistent quality and long-term supply reliability for customers. It strengthens Symrise’s competitive position in Asia’s beauty market and signals continued investment in protected, multifunctional innovations.
Global protection
The granted China right belongs to an international patent family already issued in the United States, Korea, Japan, Brazil and India, reflecting the technology’s relevance across markets.
Source: Symrise
